ISRCTN11175684进行中（未招募）Unknown
Combining structured exercise with a high-protein low-energy diet to attenuate lean mass loss in South Asian adults living with type 2 diabetes: The COMBINE trial
niversity of Leicester0 个研究点目标入组 36 人开始时间: 2023年12月19日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. South Asian ethnicity (Self-declared ethnicity of self)
- •2. Men and women
- •3. Aged =40 and =65 years,
- •4. A clinically coded diagnosis of type 2 diabetes between 3 months and 10 years previously
- •5. HbA1c 6.5% (48 mmol/mol) to 10% (86 mmol/mol) if not taking glucose-lowering medication; 6% (42 mmol/mol) to 10% (86 mmol/mol) if taking glucose-lowering medication
- •6. Body Mass Index =27.5 and =45 kg/m2
- •7. Self-reported stable weight over the previous 6 months (<+/-5% of bodyweight)
- •8. Treatment stable; no significant change to glucose-lowering regimen in the preceding 3 months, as determined by a study investigator
- •9. Able to provide informed consent
- •10. Able to understand written and spoken English or willing to use the University Hospitals of Leicester professional interpreter service
- •11. Able to take part in structured exercise training requiring the lower limbs (e.g., able to walk without assists or impairment)
- •12. Willingness and availability to participate in the proposed interventions to which they may be assigned, including attendance of intervention visits such as exercise sessions and adoption of Low Energy Diet which requires abstinence from alcohol
- •13. Willingness to self-monitor glucose, blood pressure and weight
排除标准
- •1. Individuals with type 1, gestational or monogenic diabetes mellitus
- •2. On insulin therapy (NOTE: No COMBINE participant will be on insulin at baseline as this is an exclusion criterion. An exception may made for women who are on insulin because of its lack of teratogenic effects rather than because of the inability to control glycaemia on oral agents alone)
- •3. Drugs or conditions thought by the investigators to have a significant impact on the study protocol or outcomes
- •4. Serum alanine transaminase level >2.5-fold above the upper limit of the reference range
- •5. eGFR <45 ml.min-1 per 1.73m2
- •6. Currently participating in a weight reduction program in addition to routine care
- •7. Previous bariatric surgery
- •8. Currently on oral or injected steroids
- •9. Currently on weight loss medications (not including glucose-lowering medication)
- •10. Conditions that could impact weight (i.e., active malignancy/treatment in the past year, pregnancy, lactation, planning to become pregnant in the next 8 months)
- •11. Individuals with a self-reported or diagnosed eating disorder
- •12. Self-reported milk protein allergy or other allergy or dietary practice that prohibits the use of meal replacement products
- •13. Previous myocardial infarction, stroke, amputation secondary to type 2 diabetes/peripheral vascular disease, or admission due to cardiovascular disease-related event within 12 months
- •14. Previous clinically diagnosed atrial fibrillation
- •15. Previous clinically diagnosed heart failure
- •16. Pacemaker or implantable cardioverter defibrillator (ICD)
- •17. Substance abuse. The requirement for alcohol abstinence during the initial 12 weeks will make it unlikely that individuals with alcohol dependence will enrol. Substance abuse will be queried.
- •18. Presenting with cardiac abnormalities during the exercise electrocardiogram test (inclusive of very high blood pressure)
- •19. Currently receiving or requiring active treatment for retinopathy.
- •20. Current participation in another research study with investigational medical product
- •21. Severe Intolerance or unwillingness/inability to undertake Mixed Meal Tolerance Test (Severity of intolerance to be assessed by a member of the research team during screening visit)
研究者
相似试验
招募中
不适用
Protein supplementation and exercise training to increase muscle protein synthesis rates in patients with advanced chronic kidney diseaseSkeletspier aandoeningenmuscle massmuscle protein synthesisSarcopenia10029149NL-OMON56016niversiteit Maastricht62
尚未招募
不适用
Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenia (MENTORS)Diseases of the musculoskeletal system and connective tissueKCT0006400Seoul National University Bundang Hospital168
Unknown
不适用
Lifestyle Modifications for the Treatment of Sarcopenic ObesitySarcopenic ObesitySarcopeniaObesityNCT02379026Queen Margaret University18
招募中
Unknown
Combined Exercise and Nutrition intervention for Possible Sarcopenia among community-dwelling older adults in Primary care: A Randomized Controlled TrialKCT0008779Kyung Hee University94
已完成
不适用
High Protein Dairy Products and Resistance Exercise in the ElderlyDairy ProductsWhey ProteinResistance TrainingOlder AdultsNCT06412302Universidad de O´Higgins18